| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Email: |
y.liu@mail.biobiopha.com |
| Products Intro: |
Product Name:Dauricumine
CAS:345641-00-1
Purity:98.0% Package:5mg Remarks:BBP05165
|
| Company Name: |
Chengdu Push Bio-Technology Co., Ltd.
|
| Tel: |
028-028-85370565-229-229 18080489829 |
| Email: |
18080489829@163.com |
| Products Intro: |
Product Name:Dauricumine
CAS:345641-00-1
Purity:98% Package:5mg
|
|
| | Dauricumine Basic information |
| Product Name: | Dauricumine | | Synonyms: | Dauricumine;Spiro[3-cyclopentene-1,10'-[3a,7a]propano[1H]indole]-2,5'(4'H)-dione, 9'-chloro-2',3'-dihydro-5-hydroxy-4,6',7'-trimethoxy-1-methyl-, (1R,3'aS,5R,7'aS,9'S)- | | CAS: | 345641-00-1 | | MF: | C19H24ClNO6 | | MW: | 397.85 | | EINECS: | | | Product Categories: | | | Mol File: | 345641-00-1.mol |  |
| | Dauricumine Chemical Properties |
| Melting point | 205 °C (decomp) | | Boiling point | 667.3±55.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | pka | 11.05±0.70(Predicted) |
| | Dauricumine Usage And Synthesis |
| Uses | Dauricumine is a chlorinated alkaloid that inhibits NF-κB ligand-induced differentiation of mouse bone marrow-derived macrophages into multinucleated osteoclasts[1][2]. | | References | [1] Sugimoto Y, et, al. Chlorinated alkaloids in Menispermum dauricum DC: root culture. J Org Chem. 2001 May 18;66(10):3299-302. DOI:10.1021/jo001494l
[2] Lee JY, et, al. Anti-osteoclastogenic effects of isoquinoline alkaloids from the rhizome extract of Sinomenium acutum. Arch Pharm Res. 2016 May;39(5):713-20. DOI:10.1007/s12272-016-0734-8 |
| | Dauricumine Preparation Products And Raw materials |
|